Centeno, Christopher J.
Money, Brandon T.
Dodson, Ehren http://orcid.org/0000-0002-5808-6068
Stemper, Ian
Steinmetz, Neven J.
Article History
Received: 1 April 2022
Accepted: 23 June 2022
First Online: 18 July 2022
Declarations
:
: Approval of the clinical registry was obtained through the International Cellular Medicine Society Institutional Review Board (OHRP #IRB00002637).
: Informed consent was obtained from all individual participants included in the study.
: Consent to publish has been obtained from all participants.
: One or more of the authors has declared a potential conflict of interest. ED, IS, and NJS are employed by Regenexx, LLC. CJC is a shareholder, patent holder, and Chief Medical Officer of Regenexx, LLC, and an owner of the Centeno-Schultz Clinic. BTM is employed by the Centeno-Schultz Clinic.